Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Hoosier Cancer Research Network
AstraZeneca
University of Kentucky
Fundación GECP
Masonic Cancer Center, University of Minnesota
Albert Einstein College of Medicine
Boston Scientific Corporation
Sun Yat-sen University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Barbara Ann Karmanos Cancer Institute
National Institutes of Health Clinical Center (CC)